Enterprise Value
N/A
5 min ago
Summary
- RARE enterprise value is not available.
Performance
RARE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RARE Enterprise Value Trends
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
todaytoday | - | -3.0% | -3.0% |
1 m1 month | - | +4.5% | +4.5% |
3 m3 months | - | -10.1% | -10.1% |
6 m6 months | - | -24.3% | -24.4% |
ytdytd | - | +2.6% | +2.6% |
1 y1 year | - | +3.0% | -8.2% |
5 y5 years | - | +15.9% | -27.3% |
RARE Enterprise Value Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | ||||
3 m | 3-month | $4.32 B | $4.16 B | ||
6 m | 6-month | $5.24 B | $3.93 B | ||
1 y | 1-year | $5.24 B | $3.10 B | ||
3 y | 3-year | $5.85 B | $2.01 B | ||
5 y | 5-year | $12 B | $1.56 B | ||
alltime | all time | $12 B | $947 M |
Ultragenyx Pharmaceutical Enterprise Value History
Date | Value |
---|---|
2022 | $3.15 B(-43.4%) |
2021 | $5.57 B(-35.2%) |
2020 | $8.58 B(+314.0%) |
2019 | $2.07 B(-1.2%) |
Date | Value |
---|---|
2018 | $2.10 B(+7.7%) |
2017 | $1.95 B(-28.9%) |
2016 | $2.74 B(-35.8%) |
2015 | $4.27 B(+210.0%) |
2014 | $1.38 B |
FAQ
- What is the all time high enterprise value for Ultragenyx Pharmaceutical?
What is the all time high enterprise value for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high enterprise value is $11.58 B